Ottobock receives maintained ‘Buy’ rating from Jefferies

Jefferies has maintained its ‘Buy’ rating for the prosthetics manufacturer Ottobock, setting a price target of 83 euros.

In a study released Tuesday, analyst Henrik Paganetty noted that recent financial results support a positive outlook for the company. The assessment highlights strong second-quarter results and an upwardly revised forecast for organic revenue growth in the core business through 2026. The analyst suggested that Ottobock is well-positioned to benefit from structural growth and consolidation opportunities within the end-consumer market.